[Itraconazole in the treatment of ophthalmomycoses].
The method and results of the use of itrakonazol, a new antifungal agent of the imidazol class, in the treatment of fungal diseases of the eye are described. The clinical trials involved 50 patients with various clinical forms of ophthalmomycosis: 27 patients with fungal affection of the cornea, 3 patients with fungal endophthalmitis, 8 patients with fungal canaliculitis, 3 patients with fungal blepharitis and 9 patients with fungal conjunctivitis. The clinical trials showed that itraconazole had a sufficiently high antifungal activity in the treatment of the ophthalmomycoses. The drug is low toxic and well tolerated.
Maĭchuk
Iu F
IuF
Diadina
U V
UV
D001762:Blepharitis / Q000188:drug therapy; D003231:Conjunctivitis / Q000188:drug therapy; D003316:Corneal Diseases / Q000188:drug therapy; D009877:Endophthalmitis / Q000188:drug therapy; D015821:Eye Infections, Fungal / Q000188:drug therapy*; D006801:Humans; D017964:Itraconazole / Q000009:adverse effects / Q000627:therapeutic use*
D017964:Itraconazole
Itrakonazol v lechenii oftal'momikozov.